Explore our certified commercial inventory and custom-synthesized research-grade active pharmaceutical ingredients (APIs).
Comprehensive overview of the global organic intermediate supply chain, regulatory evolution, and industrial chemical manufacturing shifts.
In the contemporary global pharmaceutical and fine chemical manufacturing domain, the demand for high-purity Organic Intermediates and customized active pharmaceutical ingredient (API) building blocks has experienced exponential growth. As pharmaceutical innovation accelerates toward targeted peptide therapies, metabolic regulators, and advanced biological conjugates, commercial entities require resilient, scalable, and audit-ready supply chain partners.
Modern industrial chemistry requires transition from legacy bench-scale batch synthesis to high-throughput, continuous flow processing under strict cGMP (Current Good Manufacturing Practice) environments. Leading global enterprise buyers, biotech innovators, and contract development and manufacturing organizations (CDMOs) face intense pressure to optimize raw material supply chains while reducing lead times, guaranteeing stereoisomeric purity, and adhering to rigorous global environmental regulations.
As a leading premier Wholesale Organic Intermediate Factory & Company, Gentolex operates at the nexus of advanced molecular synthesis, operational efficiency, and analytical rigour. By maintaining an overall factory construction area of 250,000 square meters under international standard compliance, our infrastructure is specifically engineered to mitigate global supply risks, provide seamless technology transfer from R&D to commercial production, and guarantee regulatory acceptance across North America, Europe, Latin America, and Africa.
Our main services focus on supplying peptides APIs and Custom Peptides, FDF license out, Technical Support & Consultation, Product Line and Lab Setup, Sourcing & Supply Chain Solutions.
An overall factory construction area of 250,000 square meters under international standard to offer flexible, scalable and cost-effective solutions for large-scale industrial intermediate manufacturing and specialty chemical synthesis.
Gentolex offers an extensive range of APIs and intermediates for development study and commercial application with cGMP standard from long-term collaborations. Documents and Certificates (COA, DMF, ISO) are supported to customers worldwide.
Pioneering analytical methodology, stereospecific peptide chemistry, and process optimization. We enable rapid scale-up from milligram laboratory synthesis to metric ton multi-kilogram commercial launch batches.
For those clients who prefer to avoid the complexity of dealing with multiple points of contact, we provide extra customized procurement services with the most superior and comprehensive supply chain sources globally.
Integrating artificial intelligence predictive chemistry, green catalytic routes, and continuous-flow technology to redefine global fine chemical manufacturing.
Our technical roadmap is designed to address the emerging demands of complex biological target synthesis, peptide-drug conjugates (PDCs), and novel peptide therapeutics (such as GLP-1 analogues, mitochondrial targeted peptides, and neuroactive compounds). Through strategic R&D investments, we bridge fundamental chemical synthesis with scalable industrial production.
Optimizing Solid-Phase Peptide Synthesis (SPPS) combined with Liquid-Phase Peptide Synthesis (LPPS) to maximize crude yield, reduce solvent usage by 45%, and achieve ultra-high purity for long-chain peptides.
Leveraging advanced noble metal catalyst platforms, including specialized Rhodium(III) derivatives, for highly stereoselective carbon-carbon coupling and asymmetric hydrogenations in API synthesis.
Implementing closed-loop solvent recovery units, enzymatic transformation processes, and real-time Process Analytical Technology (PAT) to meet stringent ISO 14001 environmental standards.
Gentolex’s goal is to create opportunities connecting the world with better services and guaranteed products. Up to date, Gentolex Group has been serving customers from more than 10 countries, specially, representatives are established in Mexico and South Africa.
Our main services focus on supplying peptides APIs and Custom Peptides, FDF license out, Technical Support & Consultation, Product Line and Lab Setup, Sourcing & Supply Chain Solutions.
Through our dedicated international logistics networks, stringent analytical control (HPLC, LC-MS, NMR, Heavy Metal Testing), and robust regulatory support, we ensure that every batch of organic intermediates meets or exceeds client specifications.
Explore our latest peer-reviewed manufacturing overviews, peptide research breakthroughs, and active pharmaceutical ingredient documentation.
Introduction to Selank Acetate API: Selank Acetate API is a synthetic heptapeptide active pharmaceutical ingredient (API) composed of the amino acid sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP). Originally developed through neuropharmacological research, Selank is a derivative of the endogenous tetrapeptide tuftsin, modified to offer enhanced metabolic stability and neuroprotective properties.
Read Full Monograph
Trusted Thymosin Beta-4 API Manufacturer: As a professional Thymosin Beta-4 API manufacturer and supplier, we provide high-quality Thymosin Beta-4 peptide API solutions for biotechnology companies, pharmaceutical research organizations, and clinical entities. Tβ4 plays a pivotal role in cell migration, tissue regeneration, and inflammatory modulation.
Read Full Monograph
Introduction to BPC-157 API: BPC-157 API is a synthetic pentadecapeptide that has gained increasing attention in peptide research due to its potential biological activities related to tissue repair, gastrointestinal protection, angiogenesis, and inflammatory regulation. Manufactured via state-of-the-art SPPS methods.
Read Full Monograph
With the continuous development of neuroscience, peptide technology, and life science research, neuroactive peptides have become an important area of scientific investigation. Semax, a synthetic peptide derived from an ACTH fragment, has attracted attention among researchers due to its unique molecular profile.
Read Full Monograph
SS-31 (Elamipretide) API: SS-31 API, also known as Elamipretide, MTP-131, Bendavia, and SS31, is a synthetic mitochondria-targeting tetrapeptide designed to bind cardiolipin in the inner mitochondrial membrane. By stabilizing mitochondrial structure and supporting cellular bioenergetics, SS-31 has gained significant clinical research interest.
Read Full MonographPartnering with globally recognized logistics and regulatory compliance organizations to ensure seamless international distribution.
High-purity metabolic agents, custom amino acid derivatives, and precursor intermediates available for bulk global procurement.
Addressing key regulatory, operational, and chemical synthesis inquiries from corporate procurement officers and research directors.
Gentolex provides comprehensive regulatory dossiers for commercial batches, including Certificates of Analysis (COA), HPLC purity profiles, Liquid Chromatography-Mass Spectrometry (LC-MS) data, Proton NMR spectra, Heavy Metal analyses, and residual solvent reports. For selected APIs, Drug Master Files (DMF) and cGMP compliance certificates are available upon agreement.
Our state-of-the-art facilities leverage hybrid SPPS and LPPS technology platforms. We accommodate custom synthesis requirements ranging from milligram research quantities to multi-kilogram pilot programs and metric-ton commercial scale production, maintaining purity levels up to 99% with strict stereoisomeric control.
Gentolex operates global regional hubs, including dedicated representative centers in Mexico and South Africa. We handle international cold-chain logistics, customs clearances, and regulatory import/export documentation to ensure safe and compliant door-to-door delivery across more than 10 countries worldwide.
Yes. Beyond raw organic intermediate supply, Gentolex offers full Technical Support & Consultation, FDF license-out agreements, product line establishment, and laboratory infrastructure setup for pharmaceutical companies expanding their internal manufacturing capabilities.